pc 버전으로 이동 중 [시장보고서]환자 모니터링 기기 시장 - 세계 시장 인사이트, 경쟁 상황 및 시장 예측(2030년)
환자 모니터링 기기 시장 - 세계 시장 인사이트, 경쟁 상황 및 시장 예측(2030년)
Patient Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
상품코드 : 1439683
리서치사 : DelveInsight Business Research LLP
발행일 : 2024년 02월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,250 ₩ 5,870,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,375 ₩ 8,805,000
PDF (2-3 user license) help
PDF 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,500 ₩ 11,740,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 12,750 ₩ 17,610,000
PDF (Global License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계 환자 모니터링 기기 시장 규모는 2023년 352억 1,000만 달러에 달했습니다. 이 시장은 2024년부터 2030년까지 예측 기간 동안 8.20%의 CAGR로 성장하여 2030년에는 564억 6,000만 달러에 달할 것으로 예상됩니다. 환자 모니터링 기기에 대한 수요 증가는 주로 다양한 만성 질환 및 생활습관병의 유병률 증가에 기인합니다. 또한, COVID-19의 갑작스러운 발병도 환자 모니터링 기기 시장에 기여하고 있습니다. 또한, 환자와 의료 서비스 제공자 사이에서 원격 환자 모니터링 시스템에 대한 선호도 증가, 제품 분야의 기술 발전 증가, 올해 다양한 환자 모니터링 기기의 승인 증가 등도 예측 기간(2024-2030년) 동안 환자 모니터링 기기 세계 시장을 잠재적으로 증가시킬 수 있는 요인 중 일부입니다. 증가시킬 수 있는 요인 중 일부입니다.

환자 모니터링 기기 시장은 심혈관 질환, 당뇨병, 암 등 다양한 만성 질환을 앓고 있는 인구의 급증으로 인해 전 세계적으로 견조한 성장이 예상됩니다. 이러한 질병을 정기적으로 모니터링하는 것은 질병의 적절한 관리와 진행을 억제하기 위해 매우 중요하기 때문입니다. 예를 들어, 당뇨병 환자의 혈당 모니터링 기기를 통한 정기적인 혈당 모니터링은 환자의 혈액 내 포도당 수치를 지속적으로 체크하는 데 필수적인 도구이며, 이를 통해 환자는 장애를 관리하고 신장, 안구 질환과 같은 다양한 당뇨병 관련 장애의 발병을 예방할 수 있습니다. 예방할 수 있습니다.

국제당뇨병연맹이 2023년에 발표한 통계에 따르면, 같은 해에 약 5억 3,700만 명의 성인(20-79세)이 당뇨병을 앓고 있는 것으로 추산됩니다. 또한, 2030년까지 당뇨병 환자는 6억 4,300만 명, 2045년까지 7억 8,300만 명으로 늘어날 것으로 예측했습니다.

또한, 헬스케어 시스템에서 원격 의료의 증가와 환자 및 의료 서비스 제공자의 원격 환자 모니터링에 대한 선호도가 높아짐에 따라 기술적으로 진보된 환자 모니터링 제품의 채택이 증가할 것으로 예상됩니다. 원격 환자 모니터링 기기에 대한 수요가 증가함에 따라 제조업체들은 의료 사물인터넷(IoMT) 및 스마트 환자 모니터링 기기와 통합된 환자 모니터링 기기 개발에도 주력하고 있습니다.

이 보고서는 세계 환자 모니터링 기기 시장을 조사하여 시장 개요와 함께 장치 유형별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 환자 모니터링 기기 시장 보고서 소개

제2장 환자 모니터링 기기 시장 주요 요약

제3장 규제 분석

제4장 환자 모니터링 기기 시장의 주요 요인 분석

제5장 환자 모니터링 기기 시장의 Porter's Five Forces 분석

제6장 환자 모니터링 기기 시장에 대한 COVID-19의 영향 분석

제7장 환자 모니터링 기기 시장 개요

제8장 환자 모니터링 기기 세계 기업 점유율 분석 - 주요 3-5개사

제9장 환자 모니터링 기기 기업과 제품 프로파일

제10장 KOL의 견해

제11장 프로젝트 접근법

제12장 DelveInsight 소개

제13장 면책사항과 문의

ksm 24.03.22
영문 목차

영문목차

Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2030 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

The global patient monitoring devices market was valued at USD 35.21 billion in 2023, growing at a CAGR of 8.20% during the forecast period from 2024 to 2030, in order to reach USD 56.46 billion by 2030. The escalating demand for patient monitoring devices is primarily attributed to the increase in the prevalence of various chronic and lifestyle-associated disorders. Moreover, the sudden outbreak of the COVID-19 pandemic has also contributed to the patient monitoring devices market. Additionally, the growing preferences for remote patient monitoring systems among the patient and healthcare providers, increase in technological advancement in the product arena, and rise in the approval of various patient monitoring devices in the current year, among others are also some of the factors responsible for potentially increasing the global patient monitoring devices market during the forecast period (2024-2030).

Patient Monitoring Devices Market Dynamics:

The market for patient monitoring devices is likely to observe a stellar growth owing to the surge in the population suffering from various chronic disorders such as cardiovascular disorder, diabetes, cancer, and others across the globe. This is because monitoring of these diseases at a regular interval is very necessary for the proper management of disorders and to restrict the progression of the same. For instance, regular blood glucose monitoring through glucose monitoring devices among the diabetic patients is an essential tool to keep a check on the glucose level in the patient's blood, thus helping the patients to manage the disorder and also prevent the development of various other diabetes-associated disorders such as kidney problems, eye disorders, among others.

According to the International Diabetes Federation's statistics published in the year 2023, an estimated 537 million adults (20-79 years) were living with diabetes in the same year. Moreover, the data also projected the diabetes cases to rise to 643 million by 2030 and 783 million by 2045.

Moreover, the rising trend of telemedicine in the healthcare system and the growing preference for remote patient monitoring among the patients and healthcare providers are also expected to increase the adoption of technologically advanced patient monitoring products. Owing to the increase in the demand for remote patient monitoring devices, the manufacturers are also shifting their focus on developing patient monitoring devices integrated with the internet of medical things (IoMT) or smart patient monitoring devices. For instance, on August 24, 2022, Smart Meter, a leader in cellular-connected remote patient monitoring (RPM) devices, data, and services, launched its iGlucose monitor for managing gestational diabetes.

Additionally, it is observed that the COVID-19 pandemic has benefited the market for patient monitoring devices. This is because the outbreak of the pandemic restricted the movement of many individuals, especially the old age population suffering from various chronic disorders to the hospitals or clinics for normal routine check-ups to prevent the transmission of the infection, thereby increasing the demand for remote patient monitoring devices, a subdivision of patient monitoring devices. In addition, the players also shifted their manufacturing capacity to develop various devices and software which could allow remote patient monitoring among the COVID-19 patients. For instance, in the year 2020, GE Healthcare deployed remote patient data monitoring technology, Mural Virtual Care Solution, to help clinicians support the most critical COVID-19 patients across the health system by providing a broad view across their ventilated patient population and help identify patients at risk of deterioration.

Further, in 2022, India-based healthcare startup Dozee developed a remote patient monitoring system that checks Covid-19 related vital signs such as respiration rate, and heart rate, among others.

Thus, all the aforementioned factors contributed to the growth of the patient monitoring devices market during the pandemic.

However, the high cost associated with these devices is one of the restraining factors for the global patient monitoring devices market.

Patient Monitoring Devices Market Segment Analysis:

Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, and Others), By Application (Cardiology, Neurology, Respiratory, and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare Settings, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type of device segment of the patient monitoring devices market, the cardiac monitoring devices subsegment is expected to hold a considerable market share in the year 2023. The rising prevalence of cardiovascular disorders (CVDs) worldwide could raise the demand for various cardiac monitoring devices. For instance, according to the facts published by the World Health Organization (WHO) in the year 2023, cardiovascular disorders are one of the leading causes of death, globally. Additionally, the source mentioned that in 2019, about 17.9 million people died from CVDs of which stroke and heart attack accounted for approximately 85% of the deaths. Thus, the increase in the number of death due to CVDs shows that the burden of cardiovascular associated disorders are increasing tremendously, worldwide, and to curb the deaths due to CVDs, patient monitoring becomes significant, thereby raising the demand for these devices during the study period.

Furthermore, companies raising funds to develop cardiac monitoring systems with various new technologies is also projected to augment the segment growth.

For instance, on November 18, 2020, OMRON Healthcare, Co., Ltd. has put additional investment into AliveCor by its parent company, OMRON Corporation, as part of a USD 65 million Series E funding for the leader in AI-based personal ECG (electrocardiogram) technology.

Also, the rise in approval of various products related to cardiac monitoring is a potential driving factor for the growth of the cardiac monitoring segment in the patient monitoring devices. For instance, in July 2020, Medtronic, a leading medical device company received the US Food and Drug Administration (FDA) clearance and CE (Conformite Europeenne) Mark approval for its LINQ II(TM) insertable cardiac monitor (ICM) with remote programming, which enables clinicians to optimize device settings without the need for patients to return to the office or hospital.

Hence, the interplay of all the above-mentioned factors is projected to boost the patient monitoring devices market in the forthcoming years.

North America is expected to dominate the overall Patient Monitoring Devices Market:

Among all the regions, North America is expected to hold a major share in the overall patient monitoring devices market in the year 2023. This domination is owing to the increase in the prevalence of various chronic and lifestyles associated disorders coupled with the increase in the adoption of advanced technology-based products, also various programs launched by the government in the region to support patient monitoring, remote patient monitoring, among others are anticipated to bolster the market.

For instance, in the year 2020, the Illinois governor launched a new Remote Patient Monitoring Program utilizing Telehealth Services and Pandemic Health Worker (PHW) Programs in partnership with OSF HealthCare and Southern Illinois University School of Medicine.

The program will reduce barriers to health and mental health services to support residents across Illinois with a focus on underserved communities and those at risk during the COVID-19 pandemic.

Also, growing chronic disorders such as respiratory disorders, cardiovascular disorders, and others would raise the demand for patient monitoring devices. For instance, according to the centers for Disease Control and Prevention (CDC) 2022, an estimated 7.8% prevalence of asthma was reported in the US in the year 2019.

Moreover, the rising aging population in the region who are more susceptible to developing various disorders is likely to increase the demand for patient monitoring. For instance, according to the data published by the United States Census Bureau 2022 data, there were 52 million people aged 65 and older in the year 2018 in the US.

Additionally, an increase in strategic business activities such as product launch, approval, collaboration, and others by the key players present in the region would provide an opportunity for the patient monitoring devices market to grow in the upcoming years in the region. Recently, in June 2020, Boston Scientific was granted the US Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx(TM) Insertable Cardiac Monitor (ICM) System, a new, long-term diagnostic device implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope.

Hence, all the above-stated factors are projected to propel the regional market growth of the patient monitoring devices during the forecast period.

Patient Monitoring Devices Market Key Players:

Some of the key market players operating in the Patient Monitoring Devices market include Abbott, Masimo, Brain Scientific Inc., Koninklijke Philips N.V., Medtronic, Boston Scientific Corporation, GE Healthcare, Omron Corporation, Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, Compumedics Limited, Dexcom, Inc., Nonin, BIOTRONIK, Natus Medical Incorporated., Hill-Rom Services, Inc., Getinge AB, SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, and others.

Recent Developmental Activities in the Patient Monitoring Devices Market:

On November 01, 2022, Masimo launched the Dual SET® Pulse Oximetry for Root®, a highly versatile patient monitoring, and connectivity hub. The first application of Dual SET® Oximetry is a significant advancement to Masimo SET®-guided critical congenital heart disease (CCHD) screening, with the CE marking and European launch of the Masimo SET® MOC-9® module and the addition of the Eve(TM) CCHD Newborn Screening Application for Root. Together, this combined solution enhances the automation of newborn screenings using Dual SET® Oximetry.

On July 27, 2022, Terumo launched the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Japan, which is manufactured by Dexcom, Inc.

On March 09, 2022, Brain Scientific received the FDA clearance for the Next-Gen NeuroCap(TM) EEG headset.

Key Takeaways from the Patient Monitoring Devices Market Report Study

Target Audience who can be benefited from the Patient Monitoring Devices Market Report Study

Frequently Asked Questions for the Patient Monitoring Devices Market:

1. What are Patient Monitoring Devices?

Patient monitoring systems are collections of machines or equipment used to constantly monitor patients through various vital signs and warning systems to detect and record changes in patient wellbeing.

2. What is the market for Global Patient Monitoring Devices?

The global Patient Monitoring Devices Market was valued at USD 35.21 billion in 2023, growing at a CAGR of 8.20% during the forecast period from 2024 to 2030 to reach USD 56.46 billion by 2030.

3. What are the drivers for Global Patient Monitoring Devices?

The major factors driving the demand for patient monitoring devices are the increase in the prevalence of various chronic and lifestyle-associated disorders. Moreover, the sudden outbreak of the COVID-19 pandemic has also contributed to the patient monitoring devices market. Additionally, the growing preferences for remote patient monitoring systems among the patient and healthcare providers, increase in technological advancement in the product arena, and rise in the approval of various patient monitoring devices in the current year, among others are also some of the factors responsible for potentially increasing the global patient monitoring devices market during the forecast period (2024-2030).

4. Who are the key players operating in Global Patient Monitoring Devices?

Some of the key market players operating in the Patient Monitoring Devices market include Abbott, Masimo, Brain Scientific Inc., Koninklijke Philips N.V., Medtronic, Boston Scientific Corporation, GE Healthcare, Omron Corporation, Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, Compumedics Limited, Dexcom, Inc., Nonin, BIOTRONIK, Natus Medical Incorporated., Hill-Rom Services, Inc., Getinge AB, SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, and others.

5. Which region has the highest share in the Patient Monitoring Devices market?

Among all the regions, North America is expected to hold a major share in the overall patient monitoring devices market during the forecast period. This domination is owing to the increase in the prevalence of various chronic and lifestyles associated disorders coupled with the increase in the adoption of advanced technology-based products, also various programs launched by the government in the region to support patient monitoring, remote patient monitoring, among others are anticipated to bolster the market.

Table of Contents

1.Patient Monitoring Devices Market Report Introduction

2.Patient Monitoring Devices Market Executive summary

3. Regulatory Analysis

4. Patient Monitoring Devices Market Key factors analysis

5. Patient Monitoring Devices Porter's Five Forces Analysis

6. COVID-19 Impact Analysis on Patient Monitoring Devices Market

7. Patient Monitoring Devices Market layout

8. Patient Monitoring Devices Global Company Share Analysis - Key 3-5 Companies

9. Patient Monitoring Devices Company and Product Profiles

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기